Document is current
Any future updates will be listed below
-
Authors
Chissaque, Assucênio http://orcid.org/0000-0002-9470-6068
Cassocera, Marta
Gasparinho, Carolina
Langa, Jéronimo Souzinho
Bauhofer, Adilson Fernando Loforte
Chilaúle, Jorfélia José
João, Eva Dora
Munlela, Benilde António
Sambo, Júlia Assiat Monteiro
Boene, Simone Salvador
Djedje, Marlene Bernardo
Anapakala, Elda Muianga
Guimarães, Esperança Lourenço
Bero, Diocreciano Matias
Manhique-Coutinho, Lena Vânia
Cossa-Moiane, Idalécia
Kellogg, Timothy A.
Gonçalves, Luzia Augusta Pires
de Deus, Nilsa
-
Funding
Funding for this research was provided by:
Gavi, the Vaccine Alliance through Health System Strengthening
European Foundation Initiative for African Research into Neglected Tropical Diseases (Grant no: 89539)
Deutsche Forschungsgemeinschaft (JO369/5-1)
Fundo Nacional de Investigação
World Health Organization
- License Information
-
More Information
Article History
Received: 22 July 2020
Accepted: 17 December 2020
First Online: 6 January 2021
Ethics approval and consent to participate
: The ViNaDia Protocol was approved by the National Health Bioethics Committee of Mozambique (CNBS) under number (IRB00002657, reference Nr: 348 / CNBS / 13). Administrative permissions to access raw data were not required. Participant’s anonymity and confidence were guaranteed. The participant’s documents were stored in a secure and access-restricted location in the INS. Parents or legal guardians of the children signed the informed consent form this document described the study objectives and clarified that participation in the study was voluntary and that refusal participation would not result in any penalty or loss of medical care.
: Not applicable.
: The authors have no conflicts of interest to declare.
